cardiac contractility
Conditions
Interventions
None listed
Sponsors
Catharina-ziekenhuis
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, an adult patient (males and females) must have been scheduled to have an ablation procedure to treat ventricular premature contractions and/or ventricular tachycardia. In addition, in the ablation procedure intra-arterial blood pressure monitoring, or arterial puncture should be standard of care in order to overcome arterial puncturing solely for the study. Patient also needs to be fluent in Dutch and be willing and able to provide informed consent (has the functional capacity for medical decision-making).
Exclusion criteria
Exclusion criteria: A potential subject will be excluded from participation in this study if he/she is not willing or able to provide informed consent, is diagnosed with NYHA class III or IV or diastolic heart failure, and/or there is presence of wounds, injuries or infectious diseases on the skin where the wrist-wearable device will be placed. Patients in atrial fibrillation are excluded from participation as atrial pacing for the study protocol is not possible. In addition, inpatients will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary study parameters are simultaneous ECG, ABP, PPG, and accelerometer recordings that can be used to study the correlation between ABP and PPG signals and the differences between patients with failing and non-failing hearts. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not applicable. | — |
Countries
Netherlands
Outcome results
None listed